SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-021909
Filing Date
2023-05-15
Accepted
2023-05-15 06:04:02
Documents
59
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ikna-20230331.htm   iXBRL 10-Q 2277508
2 EX-31.1 ikna-ex31_1.htm EX-31.1 21191
3 EX-31.2 ikna-ex31_2.htm EX-31.2 21258
4 EX-32.1 ikna-ex32_1.htm EX-32.1 20923
  Complete submission text file 0000950170-23-021909.txt   6946949

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ikna-20230331_cal.xml EX-101.CAL 42988
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ikna-20230331_pre.xml EX-101.PRE 238568
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ikna-20230331.xsd EX-101.SCH 40284
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ikna-20230331_def.xml EX-101.DEF 127220
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ikna-20230331_lab.xml EX-101.LAB 344848
53 EXTRACTED XBRL INSTANCE DOCUMENT ikna-20230331_htm.xml XML 1155791
Mailing Address 50 NORTHERN AVE. BOSTON MA 02210
Business Address 50 NORTHERN AVE. BOSTON MA 02210 857-343-8292
Ikena Oncology, Inc. (Filer) CIK: 0001835579 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40287 | Film No.: 23918089
SIC: 2836 Biological Products, (No Diagnostic Substances)